-
公开(公告)号:US20060194857A1
公开(公告)日:2006-08-31
申请号:US10563361
申请日:2004-07-13
IPC分类号: A61K31/4196 , A61K31/4172 , A61K31/401 , A61K31/415
CPC分类号: C07D207/333
摘要: A heteroaryl derivative of the formula (1): (wherein Ring Z is an optionally substituted heteroaryl, R1 is a carboxyl group or an alkoxycarbonyl group, etc., W1 and W2 are an optionally substituted lower alkylene, Ar1 is an optionally substituted arylene or an optionally substituted heteroarylene, W3 is a single bond, a lower alkylene, a lower alkenylene, etc., W4 is a single bond, —NR10—, etc., Ar2 is an optionally substituted aryl or an optionally substituted heteroaryl), or a prodrug thereof, or a pharmaceutically acceptable salt thereof.
摘要翻译: 式(1)的杂芳基衍生物:(其中环Z是任选取代的杂芳基,R 1是羧基或烷氧基羰基等,W 1, 和W 2是任选取代的低级亚烷基,Ar 1是任选取代的亚芳基或任选取代的亚杂芳基,W 3是单键 ,低级亚烷基,低级亚烯基等,W 4是单键,-NR 10 - 等,Ar 2, 是任选取代的芳基或任选取代的杂芳基)或其前药,或其药学上可接受的盐。
-
公开(公告)号:US20080306275A1
公开(公告)日:2008-12-11
申请号:US12173792
申请日:2008-07-15
IPC分类号: C07D233/58 , C07D401/14
CPC分类号: C07D207/333
摘要: A heteroaryl derivative of the formula (1): (wherein Ring Z is an optionally substituted heteroaryl, R1 is a carboxyl group or an alkoxycarbonyl group, etc., W1 and W2 are an optionally substituted lower alkylene, Ar1 is an optionally substituted arylene or an optionally substituted heteroarylene, W3 is a single bond, a lower alkylene, a lower alkenylene, etc., W4 is a single bond, —NR10—, etc., Ar2 is an optionally substituted aryl or an optionally substituted heteroaryl), or a prodrug thereof, or a pharmaceutically acceptable salt thereof.
摘要翻译: 式(1)的杂芳基衍生物:(其中环Z是任选取代的杂芳基,R 1是羧基或烷氧基羰基等,W 1和W 2是任选取代的低级亚烷基,Ar 1是任选取代的亚芳基或 任选取代的杂亚芳基,W3是单键,低级亚烷基,低级亚烯基等,W4是单键,-NR10-等,Ar2是任选取代的芳基或任选取代的杂芳基)或 前药,或其药学上可接受的盐。
-
公开(公告)号:US07425642B2
公开(公告)日:2008-09-16
申请号:US10563361
申请日:2004-07-13
IPC分类号: C07D207/00 , C07D295/00
CPC分类号: C07D207/333
摘要: A heteroaryl derivative of the formula (1): (wherein Ring Z is an optionally substituted heteroaryl, R1 is a carboxyl group or an alkoxycarbonyl group, etc., W1 and W2 are an optionally substituted lower alkylene, Ar1 is an optionally substituted arylene or an optionally substituted heteroarylene, W3 is a single bond, a lower alkylene, a lower alkenylene, etc., W4 is a single bond, —NR10—, etc., Ar2 is an optionally substituted aryl or an optionally substituted heteroaryl), or a prodrug thereof, or a pharmaceutically acceptable salt thereof.
摘要翻译: 式(1)的杂芳基衍生物:(其中环Z是任选取代的杂芳基,R 1是羧基或烷氧基羰基等,W 1, 和W 2是任选取代的低级亚烷基,Ar 1是任选取代的亚芳基或任选取代的亚杂芳基,W 3是单键 ,低级亚烷基,低级亚烯基等,W 4是单键,-NR 10 - 等,Ar 2, 是任选取代的芳基或任选取代的杂芳基)或其前药,或其药学上可接受的盐。
-
公开(公告)号:US07220773B2
公开(公告)日:2007-05-22
申请号:US10474943
申请日:2002-04-17
申请人: Ryu Nagata , Katsunori Maruta , Kiyotaka Iwai , Makoto Kitoh , Kantaro Ushiroda , Kozo Yoshida
发明人: Ryu Nagata , Katsunori Maruta , Kiyotaka Iwai , Makoto Kitoh , Kantaro Ushiroda , Kozo Yoshida
IPC分类号: C07D207/46 , A61K31/40
CPC分类号: C07D207/33 , C07D207/333 , C07D207/335 , C07D207/34 , C07D401/06 , C07D401/12 , C07D403/06 , C07D405/06 , C07D405/12 , C07D409/06 , C07D417/06
摘要: A novel pyrrole derivative represented by the following formula (1) and a salt thereof: wherein R1 means substituted alkenyl, etc.; R2 means substituted benzoyl, etc.; and R3 to R5 each means hydrogen, alkyl, halogeno, etc. The derivative and salt have antidiabetic activity.
摘要翻译: 由下式(1)表示的新型吡咯衍生物及其盐:其中R 1表示取代的烯基等; R 2表示取代的苯甲酰基等; R 3和R 5各自表示氢,烷基,卤代等。衍生物和盐具有抗糖尿病活性。
-
公开(公告)号:US07781479B2
公开(公告)日:2010-08-24
申请号:US11795147
申请日:2006-01-12
申请人: Yoko Takahashi , Ryu Nagata , Kantaro Ushiroda
发明人: Yoko Takahashi , Ryu Nagata , Kantaro Ushiroda
IPC分类号: A61K31/405 , A61K31/404 , A61K31/192 , C07D209/04 , C07D209/12
CPC分类号: C07D233/64 , C07D209/12 , C07D231/56 , C07D235/12 , C07D471/04
摘要: A compound of the following formula (1), or its prodrug or pharmaceutically acceptable salt thereof, being useful as a diabetic medicine or preventive, or blood sugar regulator, or therapeutic agent for hyperlipemia, etc. wherein the ring Z is an optionally substituted heteroaryl, W4 is a single bond, lower alkylene, etc., Ar2 is an optionally substituted aryl, etc., W3 is a single bond, lower alkylene, etc., Ar1 is an optionally substituted arylene, etc., each of W1 and W2 is an optionally substituted lower alkylene, etc., and R1 is carboxyl, an alkoxycarbonyl.
摘要翻译: 下式(1)的化合物或其前药或药学上可接受的盐可用作糖尿病药物或预防性或血糖调节剂或高脂血症治疗剂等,其中环Z为任选取代的杂芳基 W4为单键,低级亚烷基等,Ar2为任意取代的芳基等,W3为单键,低级亚烷基等,Ar1为任意取代的亚芳基等,W1,W2分别为 是任选取代的低级亚烷基等,并且R 1是羧基,烷氧基羰基。
-
公开(公告)号:US20080167306A1
公开(公告)日:2008-07-10
申请号:US11795147
申请日:2006-01-12
申请人: Yoko Takahashi , Ryu Nagata , Kantaro Ushiroda
发明人: Yoko Takahashi , Ryu Nagata , Kantaro Ushiroda
IPC分类号: A61K31/5377 , C07D207/00 , A61K31/40 , C07D209/04 , A61K31/404 , C07D213/02 , A61K31/437 , C07D231/10 , A61P9/00 , A61P3/10 , A61K31/415 , C07D235/04 , A61K31/4184 , C07D231/54 , C07D221/02 , C07D295/00
CPC分类号: C07D233/64 , C07D209/12 , C07D231/56 , C07D235/12 , C07D471/04
摘要: A compound of the following formula (1), or its prodrug or pharmaceutically acceptable salt thereof, being useful as a diabetic medicine or preventive, or blood sugar regulator, or therapeutic agent for hyperlipemia, etc. wherein the ring Z is an optionally substituted heteroaryl, W4 is a single bond, lower alkylene, etc., Ar2 is an optionally substituted aryl, etc., W3 is a single bond, lower alkylene, etc., Ar1 is an optionally substituted arylene, etc., each of W1 and W2 is an optionally substituted lower alkylene, etc., and R1 is carboxyl, an alkoxycarbonyl.
摘要翻译: 下式(1)的化合物或其前药或药学上可接受的盐可用作糖尿病药物或预防性或血糖调节剂或高脂血症治疗剂等,其中环Z为任选取代的杂芳基 ,W 4是单键,低级亚烷基等,Ar 2是任选取代的芳基等,W 3是 单键,低级亚烷基等,Ar 1是任选取代的亚芳基等,W 1和W 2中的每一个是 任选取代的低级亚烷基等,R 1是羧基,烷氧基羰基。
-
公开(公告)号:US20100286144A1
公开(公告)日:2010-11-11
申请号:US12841126
申请日:2010-07-21
申请人: Yoko TAKAHASHI , Ryu Nagata , Kantaro Ushiroda
发明人: Yoko TAKAHASHI , Ryu Nagata , Kantaro Ushiroda
IPC分类号: A61K31/5377 , C07D207/333 , A61K31/40 , C07D209/12 , A61K31/404 , C07D471/06 , A61K31/437 , C07D231/12 , A61K31/415 , C07D235/12 , A61K31/4184 , C07D413/12 , C07D231/56 , A61K31/416 , A61P3/10 , A61P3/06
CPC分类号: C07D233/64 , C07D209/12 , C07D231/56 , C07D235/12 , C07D471/04
摘要: A compound of the following formula (1), or its prodrug or pharmaceutically acceptable salt thereof, being useful as a diabetic medicine or preventive, or blood sugar regulator, or therapeutic agent for hyperlipemia, etc. wherein the ring Z is an optionally substituted heteroaryl, W4 is a single bond, lower alkylene, etc., Ar2 is an optionally substituted aryl, etc., W3 is a single bond, lower alkylene, etc., Ar1 is an optionally substituted arylene, etc., each of W1 and W2 is an optionally substituted lower alkylene, etc., and R1 is carboxyl, an alkoxycarbonyl.
摘要翻译: 下式(1)的化合物或其前药或药学上可接受的盐可用作糖尿病药物或预防性或血糖调节剂或高脂血症治疗剂等,其中环Z为任选取代的杂芳基 W4为单键,低级亚烷基等,Ar2为任意取代的芳基等,W3为单键,低级亚烷基等,Ar1为任意取代的亚芳基等,W1,W2分别为 是任选取代的低级亚烷基等,并且R 1是羧基,烷氧基羰基。
-
-
-
-
-
-